Literature DB >> 4105291

Plasma triglyceride turnover during use of oral contraceptives.

M Kekki, E A Nikkilä.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4105291     DOI: 10.1016/0026-0495(71)90050-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  18 in total

Review 1.  Complications of systemic oral contraceptive therapy: Neoplasm--breast, uterus, cervix and vagina.

Authors:  M A Sperling
Journal:  West J Med       Date:  1975-01

2.  Hyperlipidemia in pregnancy.

Authors:  R A Hegele
Journal:  CMAJ       Date:  1991-12-15       Impact factor: 8.262

3.  Synthesis of very low density lipoproteins in the cockerel. Effects of estrogen.

Authors:  L Chan; R L Jackson; B W O'Malley; A R Means
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

Review 4.  [Metabolic studies under administration of oral contraceptives. A review].

Authors:  S Hauschildt
Journal:  Z Ernahrungswiss       Date:  1978-03

Review 5.  Secondary hyperlipidaemia.

Authors:  A Chait
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1973

Review 6.  Gonadal hormones and triglycerides.

Authors:  C J Glueck; R Fallat
Journal:  Proc R Soc Med       Date:  1974-06

7.  Diet and triglyceride metabolism.

Authors:  I Macdonald
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1973

8.  Plasma triglyceride metabolism in thyroid disease.

Authors:  E A Nikkilä; M Kekki
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

9.  Serum lipids, lipoproteins and apolipoproteins in pregnant non-diabetic patients.

Authors:  J C Mazurkiewicz; G F Watts; F G Warburton; B M Slavin; C Lowy; E Koukkou
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

10.  Gene-environment interaction in the conversion of a mild-to-severe phenotype in a patient homozygous for a Ser172-->Cys mutation in the lipoprotein lipase gene.

Authors:  Y Ma; M S Liu; D Ginzinger; J Frohlich; J D Brunzell; M R Hayden
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.